We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

173 hedge funds and large institutions have $1.15B invested in Amedisys in 2015 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 57 increasing their positions, 58 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

373% more call options, than puts

Call options by funds: $8.65M | Put options by funds: $1.83M

238% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 13

22% more funds holding

Funds holding: 142173 (+31)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

2% less capital invested

Capital invested by funds: $1.17B → $1.15B (-$18.9M)

2% less repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 58

Holders
173
Holders Change
+31
Holders Change %
+21.83%
% of All Funds
4.83%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
44
Increased
57
Reduced
58
Closed
13
Calls
$8.65M
Puts
$1.83M
Net Calls
+$6.82M
Net Calls Change
+$3.91M
Name Holding Trade Value Shares
Change
Change in
Stake
KKRC
1
Kohlberg Kravis Roberts & Co
New York
$184M
NTC
2
North Tide Capital
Massachusetts
$152M
Fidelity Investments
3
Fidelity Investments
Massachusetts
$115M -$23.7M -561,400 -16%
Vanguard Group
4
Vanguard Group
Pennsylvania
$95.1M +$16.9M +399,948 +19%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$72.7M -$147K -3,491 -0.2%
BFA
6
BlackRock Fund Advisors
California
$69.3M -$5.74M -136,188 -7%
BA
7
BlackRock Advisors
Delaware
$33.7M +$21.5M +510,306 +135%
Northern Trust
8
Northern Trust
Illinois
$27.7M +$3.72M +88,110 +14%
BIT
9
BlackRock Institutional Trust
California
$25.8M -$6.19M -146,837 -18%
State Street
10
State Street
Massachusetts
$23.6M +$719K +17,042 +3%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$19.3M -$8.84M -209,557 -29%
BG
12
BlackRock Group
United Kingdom
$18.8M +$11.1M +262,872 +113%
Deutsche Bank
13
Deutsche Bank
Germany
$14.8M +$2.36M +55,985 +17%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$13.3M +$1.55M +36,774 +12%
Norges Bank
15
Norges Bank
Norway
$13.1M +$4.83M +114,600 +50%
Millennium Management
16
Millennium Management
New York
$10.8M -$11.1M -262,725 -48%
Morgan Stanley
17
Morgan Stanley
New York
$10.4M +$1.35M +32,052 +13%
Invesco
18
Invesco
Georgia
$10.2M +$2.41M +57,145 +27%
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
$8.82M +$9.79M +232,161 New
Geode Capital Management
20
Geode Capital Management
Massachusetts
$8.24M +$255K +6,039 +3%
TCIM
21
TIAA CREF Investment Management
New York
$7.93M +$1.9M +45,118 +28%
PPA
22
Parametric Portfolio Associates
Washington
$7.3M -$720K -17,067 -8%
BIM
23
Bogle Investment Management
Massachusetts
$7.28M +$8.08M +191,662 New
CM
24
Castleark Management
Illinois
$7.18M +$7.98M +189,135 New
HAI
25
Hennessy Advisors Inc
California
$7.14M +$321K +7,600 +4%

AMED Hedge Fund Activity: Q3 2015 in Review

173 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q3 2015, worth a combined $1.15B — down 1.6% from $1.17B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new AMED positions and 13 closed out — a net gain of 31 holders — while 57 added to existing stakes and 58 trimmed.

The largest buyer was BlackRock Advisors, adding an estimated $21.5M. The largest seller was Fidelity Investments, cutting an estimated $23.7M.

  • 173 institutional investors held Amedisys (AMED) as of Q3 2015, up from 142 in Q2 2015.
  • Funds reported $1.15B of Amedisys stock for Q3 2015, down 1.6% quarter-over-quarter.
  • 44 funds opened new Amedisys positions in Q3 2015 and 13 closed out, a net change of +31 holders.
  • The largest Amedisys buyer in Q3 2015 was BlackRock Advisors, an estimated $21.5M added.
  • The largest Amedisys seller in Q3 2015 was Fidelity Investments, an estimated $23.7M sold.

Based on aggregated 13F filings for Q3 2015.